	C 2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	654	764	1,084	1,291	1,357	1,411	1,685	2,279	2,599	3,238	3,765	4,512	4,506	4,482	5,366
Cost of Operating Revenue	475	531	724	864	831	802	1,038	1,436	1,499	1,653	2,169	2,640	2,407	2,128	2,172
Gross Profit	179	234	360	427	526	608	646	843	1,100	1,585	1,596	1,872	2,100	2,354	3,194
Gross Margin	27.3	30.6	33.2	33.1	38.8	43.1	38.4	37.0	42.3	49.0	42.4	41.5	46.6	52.5	59.5
Total Operating Expenses	607	702	955	1,135	1,140	1,178	1,482	2,000	2,177	2,524	3,190	3,774	3,854	3,757	4,477
Operating Profit	47	63	129	156	218	233	202	279	422	713	575	738	653	725	889
Operating Margin	7.2	8.2	11.9	12.1	16.0	16.5	12.0	12.2	16.2	22.0	15.3	16.3	14.5	16.2	16.6
Financing Income/(Expense) - Net	-16	-16	-19	-31	-32	-33	-23	-8	2	-22	-17	-58	-105	-100	-114
Profit before Taxes	43	46	112	128	186	205	196	326	451	704	558	687	547	660	785
Income Taxes	13	14	37	37	61	65	63	89	135	155	145	171	142	159	190
Profit after Tax	30	33	75	91	123	165	133	236	335	549	413	517	405	502	595
PAT Margin	4.6	4.3	6.9	7.0	9.1	11.7	7.9	10.4	12.9	17.0	11.0	11.4	9.0	11.2	11.1
EPS - Basic - ex Extraordinary Items	1.49	1.62	0.37	0.45	5.95	7.52	5.49	9.30	12.45	22.05	16.65	21.05	16.73	20.69	24.47
EPS - Diluted - ex Extraordinary Items	1.49	1.58	0.36	0.44	5.83	7.48	5.47	9.28	12.41	21.95	16.60	21.02	1.67	20.68	24.46
EBIT	47	63	129	156	218	233	202	279	422	713	575	738	653	725	889
EBITDA	72	86	159	209	278	310	278	384	559	865	734	922	860	950	1,185
EBITDA Margin	10.9	11.2	14.6	16.2	20.5	22.0	16.5	16.9	21.5	26.7	19.5	20.4	19.1	21.2	22.1

Balance Sheet

Abridged

Understanding Balance Sheet

Granules India Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	C 2013 Mar 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	260	289	377	666	818	828	1,187	1,282	1,629	1,997	2,505	2,574	2,905	3,115	3,768
Long-Term Investments	0	0	0	1	1	14	33	39	19	19	20	21	22	23	23
Property Plant & Equipment - Net	263	359	499	470	554	699	991	1,071	1,137	1,256	1,596	1,859	2,116	2,654	3,458
Total Non-Current Assets	311	394	615	646	745	1,051	1,491	1,701	1,600	1,716	2,008	2,330	2,616	3,137	3,952
Total Assets	571	683	992	1,312	1,563	1,879	2,677	2,983	3,228	3,713	4,513	4,905	5,521	6,253	7,720
Total Current Liabilities	214	206	293	586	655	787	878	896	893	1,173	1,642	1,814	2,082	2,003	2,092
Long Term Debt	88	175	309	243	184	124	433	479	422	341	242	219	152	471	458
Total Non-Current Liabilities	113	202	344	295	247	188	495	557	491	367	284	256	213	534	543
Total Liabilities	326	408	636	881	901	975	1,373	1,453	1,385	1,540	1,926	2,070	2,295	2,537	2,635
Total Shareholders' Equity	245	275	356	431	662	904	1,304	1,529	1,844	2,173	2,587	2,835	3,226	3,716	5,085
Minority Interest	-	-	-	-	-	-	-	-	-	-	1	-	-	-	-
Total Equity	245	275	356	431	662	904	1,304	1,529	1,844	2,173	2,587	2,835	3,226	3,716	5,085
Total Liabilities & Equity	571	683	992	1,312	1,563	1,879	2,677	2,983	3,228	3,713	4,513	4,905	5,521	6,253	7,720

Cash Flow

Abridged

Understanding Cash Flow Statement

Granules India Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	53	62	119	152	199	213	201	318	440	697	577	701	586	761	820
Working Capital - Increase/(Decrease)	-44	15	-31	-31	-80	-52	-230	-76	13	-275	-257	-10	-246	6	-142
Net CF from Operating Activities	9	77	88	120	119	161	-29	242	453	422	320	691	340	767	678
Capital Expenditures - Net	55	116	265	147	161	316	446	279	184	271	397	410	379	570	555
Net CF from Investing Activities	-55	-131	-256	-148	-166	-331	-465	-277	-164	-293	-392	-196	-363	-695	-779
Dividends Paid - Cash - Total	3	5	5	8	23	22	29	31	31	25	37	19	36	36	36
Stock - Issuance/(Retirement) - Net	0	1	1	1	133	83	293	1	-	-173	4	-308	3	5	667
Debt - LT & ST - Issuance/(Retirement) - Total	69	68	171	58	13	27	296	40	-156	-75	248	-60	143	42	-131
Net Cash Flow from Financing Activities	66	64	167	51	123	88	560	10	-186	-273	214	-387	110	11	500
Free Cash Flow to Equity	24	28	-6	31	-29	-128	-180	3	113	75	171	220	104	239	-8
Free Operating CF net dividend	-49	-45	-183	-36	-67	-178	-505	-68	238	126	-115	261	-77	159	84
Free Operating CF	-46	-40	-178	-28	-43	-156	-476	-38	268	150	-78	280	-41	195	120

Business Segment Analysis

FY End:

Mar 25

Granules India Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharmaceutical products (100.0%)₹ 571.69 Cr

Revenue / Sales

Pharmaceutical products (100.0%)₹ 4,481.61 Cr

Assets

Pharmaceutical products (100.0%)₹ 6,252.56 Cr

Operating Income

Pharmaceutical products (100.0%)₹ 724.69 Cr

Regional Segment Analysis

FY End:

Mar 25

Granules India Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Outside India (94.0%)₹ 4,210.78 CrIndia (6.0%)₹ 270.83 Cr

Historical Segment Analysis

Track how Granules India Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Pharmaceutical products	184	271	398	411	381	572

Frequently Asked Questions

What is the revenue of Granules India Ltd.?

The latest trailing twelve month revenue of Granules India Ltd. is ₹ 5,365.64 Cr, reflecting a 1-year growth of 19.73% and a 3-year CAGR of 5.95%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Granules India Ltd.?

The latest trailing twelve month net profit (PAT) of Granules India Ltd. is ₹ 595.02 Cr, with a 3-year earnings CAGR of 5.18%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Granules India Ltd.?

The trailing twelve month EBITDA of Granules India Ltd. is approximately ₹ 889.00 Cr (based on an operating margin of 16.57%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Granules India Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Granules India Ltd. is 24.46. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Granules India Ltd.?

The debt-to-equity ratio of Granules India Ltd. stands at 0.30. The interest coverage ratio is 7.77x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Granules India Ltd.?

The estimated book value per share of Granules India Ltd. is 213.62 (derived from a P/B ratio of 4.19 and market price of ₹ 894.80), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Granules India Ltd.?

The trailing twelve month operating cash flow of Granules India Ltd. is ₹ 678.42 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Granules India Ltd. report consolidated or standalone financials?

Granules India Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.